News / Health

    Immune Drugs Hold Hope of 'Clinical Cure' for Melanoma

    FILE - Dr. Antonella Tost, Dermatologist University of Miami School of Medicine, examines Michael Casa Nova, 12, for symptoms of skin cancer due to sun exposure, June 15, 2011.
    FILE - Dr. Antonella Tost, Dermatologist University of Miami School of Medicine, examines Michael Casa Nova, 12, for symptoms of skin cancer due to sun exposure, June 15, 2011.
    Reuters
    A new generation of drugs designed to trigger the immune system to fight cancer is offering the prospect of a “clinical cure” for some melanoma skin cancer patients who until a few years ago were more likely to be facing a swift death.
     
    Cancer specialists gathering for a European conference at the weekend said the so-called immunotherapy drugs, a class led by Bristol-Myers Squibb's Yervoy, or ipilimumab, have transformed an area of oncology in which until recently doctors barely had time to get to know their patients.
     
    Stephen Hodi, assistant professor of medicine at the Dana-Farber Cancer Institute in the United States, said he was cautious about using the term cure, but described recent advances as a “paradigm shift”.
     
    At the least, he said, the success of this new generation of medicines means some melanoma patients would now be living with a chronic disease, rather than facing imminent death.
     
    “This is a really amazing time ... A few years ago we could never have imagined using the C-word, cure, in melanoma,” he said. “But we are headed that way.”
     
    “Ipilimumab opened a door, and now the field is moving extremely fast,” he told Reuters at the European Cancer Congress (ECC) in Amsterdam.
     
    Yervoy, approved by regulators in 2011, was hailed as a breakthrough treatment in melanoma after it became the first drug ever to extend survival in patients with advanced forms of the melanoma, the deadliest form of skin cancer.
     
    A type of drug known as a human monoclonal antibody, it activates the body's immune system to fight the cancer by targeting a protein receptor called Cytotoxic T-Lymphocyte Antigen 4, or CTLA-4.
     
    On average, Yervoy added only about four months of life in pivotal trials, but around 20 percent of patients had an impressively durable response to the drug.
     
    Hodi presented new data at the ECC from the largest and longest study of overall survival for patients treated with Yervoy which showed some of them can survive for up to 10 years.
     
    Alexander Eggermont of the Institut Gustave Roussy Comprehensive Cancer Center in France, who specializes in the treatment of melanoma, said Hodi's results suggested some patients could be effectively cured of their cancer - a concept known as a “clinical cure” - with the drug helping the immune to keep the disease in check.
     
    “Patients apparently can keep residual tumors under control for a long time when the immune system is properly 'reset', and the concept of 'clinical cures' becomes a reality,” he said in a statement to the conference.
     
    And with a next generation of immunotherapy drugs - designed to disable proteins called PD1 and PDL1 that prevent the immune system from spotting and attacking cancer cells - already being tested alone and in combination with Yervoy, there is “tremendous promise” in the treatment of melanoma, said Hodi.
     
    Bristol-Myers Squibb is conducting late stage trials of its next-generation drug, nivolumab, in advanced melanoma, while rival U.S. drugmaker Merck is developing a competitor, lambrolizumab, which in early-stage trials helped shrink tumors in 38 percent of advanced melanoma patients.
     
    Swiss drugmaker Roche's also has a leading contender - MPDL3280A - in this class.
     
    “These [Yervoy] survival results could even double or triple with anti-PD1/PDL1 monoclonal antibodies, and metastatic melanoma could become a curable disease for perhaps more than 50 percent of patients over the coming five to 10 years,” Eggermont said.

    You May Like

    Video Somali, AU Forces Face Resurgent Al-Shabab

    Somalia’s Western backers frustrated over country’s slow progress in establishing its armed forces to bring security after 25 years of chaos

    Israel Makes Push for Gaza Strip Recovery

    After years of economic blockade and attempts to disable Hamas, Israeli leaders eventually realized that Hamas’ downfall could lead to chaos or the rise of a more radical Jihadist group

    Slump in Chinese Tourists Hitting Hong Kong Retail

    Mainland Chinese account for up to three-quarters of visitors to Hong Kong, but that number is falling, and shopping centers are struggling to 'shift gears' and maintain sales

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Somali, African Union Forces Face Resurgent Al-Shababi
    X
    Henry Ridgwell
    April 28, 2016 4:20 PM
    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Somali, African Union Forces Face Resurgent Al-Shabab

    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Bangladesh Targeted Killings Spark Wave of Fear

    People in Bangladesh’s capital are expressing deep concern over the brutal attacks that have killed secular blogger, and most recently a gay rights activist and an employee of the U.S. embassy. Xulhaz Mannan, an embassy protocol officer and the editor of the country’s only gay and transgender magazine Roopban; and his friend Mehboob Rabbi Tanoy, a gay rights activist, were hacked to death by five attackers in Mannan’s Dhaka home earlier this month.
    Video

    Video Documentary Tells Tale of Chernobyl Returnees

    Ukraine this week is marking the 30th anniversary of the world's worst nuclear accident, at the Chernobyl nuclear power plant. Soviet officials at first said little about the accident, but later evacuated a 2,600-square-kilometer "exclusion zone." Some people, though, came back. American directors Holly Morris and Anne Bogart created a documentary about this faithful and brave community. VOA's Tetiana Kharchenko reports from New York on "The Babushkas of Chernobyl." Carol Pearson narrates.
    Video

    Video Nigerians Feel Bite of Buhari Economic Policy

    Despite the global drop in the price of oil, Nigerian President Muhammadu Buhari has refused to allow the country's currency to devalue, leading to a shortage of foreign exchange. Chris Stein reports from Lagos businessmen and consumers are feeling the impact as the country deals with a severe fuel shortage.
    Video

    Video  Return to the Wild

    There’s a growing trend in the United States to let old or underused golf courses revert back to nature. But as Erika Celeste reports from one parcel in Grafton, Ohio, converting 39 hectares of land back to green space is a lot more complicated than just not mowing the fairway.
    Video

    Video West Urges Unity in Libya as Migrant Numbers Soar

    The Italian government says a NATO-led mission aimed at stemming the flow of migrants from Libya to Europe could be up and running by July. There are concerns that the number of migrants could soar as the route through Greece and the Balkans remains blocked. Western powers say the political chaos in Libya is being exploited by people smugglers — and they are pressuring rival groups to come together under the new unity government. VOA's Henry Ridgwell reports.
    Video

    Video Russia’s TV Rain Swims Against Tide in Sea of Kremlin Propaganda

    Russia’s media freedoms have been gradually eroded under President Vladimir Putin as his government has increased state ownership, influence, and restrictions on critical reporting. Television, where most Russians get their news, has been the main target and is now almost completely state controlled. But in the Russian capital, TV Rain stands out as an island in a sea of Kremlin propaganda.
    Video

    Video Kurdish Town Receives Refugees but Lacks Resources

    A wave of refugees is pouring into the Kurdish town of Afrin in northern Syria as a result of fighting between rebel forces and Islamic State militants. VOA’s Amina Misto went to the town and reports local authorities are finding it difficult to cope with this influx of internally displaced people. Bronwyn Benito narrates her report.
    Video

    Video Scientists Build Human Tissue on Animal Matrix

    The question has always been, if a gecko can grow back its tail, why can't we regenerate our lost body parts? Well, maybe we can, someday. Scientists are moving towards the ability to rebuild fully functioning organs, and have made significant progress replacing muscles and other tissue.
    Video

    Video Containing Chernobyl Radiation Continues 30 Years After Explosion

    April 26 marks the 30th anniversary of the Chernobyl nuclear disaster. Hundreds were killed following the explosion and it's estimated that thousands more have died from cancers caused by the radiation. Henry Ridgwell traveled to Chernobyl and reports for VOA on the continuing efforts to decommission the site -- and on the fledgling plans for a new future in the vast exclusion zone.
    Video

    Video Frustration Builds Among Refugees Trapped at Macedonian Border

    On the Greek border with Macedonia, 12,000 refugees continue to wait. Since the route to the rest of Europe was closed last month, the makeshift camp at Idomeni has seen protests and tear gas. But while those here wait, their frustration grows — as do reports of people attempting to find new ways of continuing their journey. John Owens reports from Idomeni.
    Video

    Video Researchers: Bees Help Kenyan Farmers Fend Off Elephants

    Elephant crop-raiding continues to be a major source of human-wildlife conflict in Kenya, so one elephant researcher is helping to alleviate the problem near Tsavo East National Park with beehive fences, which use elephants’ natural aversion to bees to deter them from farms. VOA’s Jill Craig visited the area ahead of this month's Giants Club Summit, which will bring together dignitaries at Mount Kenya to find solutions to combat poaching, the No. 1 threat to elephants.

    Special Report

    Adrift The Invisible African Diaspora